Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-3ASR Automatic shelf registration (foreign)
- 4.3 Form of Senior Teva Pharmaceutical Industries Limited Indenture
- 4.4 Form of Guaranteed Senior Finance Subsidiary Indenture
- 4.5 Form of Subordinated Teva Pharmaceutical Industries Limited Indenture
- 4.6 Form of Guaranteed Subordinated Finance Subsidiary Indenture
- 5.1 Opinion of Tulchinsky Stern Marciano Cohen Levitski & Co (Israeli Law)
- 5.2 Opinion of Willkie Farr & Gallagher LLP (New York Law)
- 5.3 Opinion of Vaneps Kunneman Vandoorne (Curacao Law)
- 12.1 Statement Re Computation of Consolidated Ratio of Earnings to Fixed Charges
- 23.1 Consent of Kesselman & Kesselman
- 25.1 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.2 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.3 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.4 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.5 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.6 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.7 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.8 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.9 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.10 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.11 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.12 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.13 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.14 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.15 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.16 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.17 Statement of the Bank of New York Mellon, Senior Indenture
- 25.18 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
- 25.19 Statement of Eligibility of the Bank of New York Mellon, Senior Indenture
- 25.20 Statement of Eligibility of the Bank of New York Mellon, Subordinated Indenture
Teva Pharmaceutical Finance Iii BV similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form F-3 of Teva Pharmaceutical Industries Limited of our reports dated February 15, 2011, relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appear in Teva Pharmaceutical Industries Limited’s Annual Report on Form 20-F for the year ended December 31, 2010. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Kesselman & Kesselman |
Tel-Aviv, Israel | Kesselman & Kesselman | |
December 8, 2011 | Certified Public Accountants (Isr.) | |
A member firm of PricewaterhouseCoopers International Limited |